| Net Cash Provided by (Used in) Operating Activities |
$1,825,105 |
USD |
|
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Financing Activities |
$1,029,108 |
USD |
-93% |
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Investing Activities |
$2,657,884 |
USD |
|
Q1 2025 |
Q1 2025 |
| Common Stock, Shares Authorized |
40,000,000 |
shares |
0% |
Q3 2025 |
Q3 2025 |
| Common Stock, Shares, Issued |
29,315,726 |
shares |
24% |
Q3 2025 |
Q3 2025 |
| Common Stock, Par or Stated Value Per Share |
0.01 |
USD/shares |
0% |
Q3 2025 |
Q3 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
$2,588,758 |
USD |
29% |
Q1 2025 |
Q1 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
$4,876,966 |
USD |
718% |
Q3 2025 |
Q3 2025 |
| Interest Paid, Excluding Capitalized Interest, Operating Activities |
$189,089 |
USD |
-12% |
Q1 2025 |
Q1 2025 |
| Deferred Tax Assets, Valuation Allowance |
$3,215,387 |
USD |
-7.3% |
Q4 2024 |
FY 2024 |
| Deferred Tax Assets, Gross |
$7,550,049 |
USD |
-7.5% |
Q4 2024 |
FY 2024 |
| Operating Lease, Liability |
$825,161 |
USD |
-11% |
Q4 2024 |
FY 2024 |
| Payments to Acquire Property, Plant, and Equipment |
$535,305 |
USD |
|
Q1 2025 |
Q1 2025 |
| Comprehensive Income (Loss), Net of Tax, Attributable to Parent |
$268,871 |
USD |
98% |
Q3 2025 |
Q3 2025 |
| Lessee, Operating Lease, Liability, to be Paid |
$1,249,054 |
USD |
-14% |
Q4 2024 |
FY 2024 |
| Property, Plant and Equipment, Gross |
$2,183,404 |
USD |
1689% |
Q3 2025 |
Q3 2025 |
| Operating Lease, Liability, Current |
$87,689 |
USD |
-27% |
Q3 2025 |
Q3 2025 |
| Operating Lease, Weighted Average Discount Rate, Percent |
0.13 |
pure |
0% |
Q4 2024 |
FY 2024 |
| Deferred Income Tax Expense (Benefit) |
$0 |
USD |
|
Q1 2024 |
Q1 2024 |
| Lessee, Operating Lease, Liability, Undiscounted Excess Amount |
$423,893 |
USD |
-19% |
Q4 2024 |
FY 2024 |
| Additional Paid in Capital |
$71,375,688 |
USD |
14% |
Q3 2025 |
Q3 2025 |
| Depreciation, Depletion and Amortization |
$43,482 |
USD |
492% |
Q1 2025 |
Q1 2025 |
| Deferred Tax Assets, Net of Valuation Allowance |
$4,334,662 |
USD |
-7.7% |
Q4 2024 |
FY 2024 |
| Share-based Payment Arrangement, Expense |
$2,881,065 |
USD |
|
Q3 2025 |
Q3 2025 |
| Interest Expense |
$1,178,954 |
USD |
172% |
Q2 2024 |
Q2 2024 |
| Preferred Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q3 2025 |
Q3 2025 |